Didier Jutras-Aswad

Principaux champs de recherche
Chercheur(e)s associé(e)s
Organisations associées

Projets de recherche récents

CRISM-Quebec-Maritimes: Research on interventions in drug misuse

2014/15-2020/21 • $2,374,845 • PI,CO,Other
Substance misuse remains a significant global public health problem which carries a heavy burden for abusers and their families alike. This disorder is indeed associated with suffering and severe health problems in patients, distress among family members, as well as tremendous costs to society....

Évaluation en temps réel du déploiement de technologies connectées et du partenariat de soins et services dans le contexte de crise sanitaire lié à la COVID-19 - le programme Techno-COVID-Partenariat

2020/21 • $502,487 • PI,CO,Other
Aux prises avec une crise sanitaire sans precedent, les deux etablissements qui recoivent le plus de patients atteints de la COVID-19 au Quebec, ont decide de mettre en place des innovations sociales et technologiques adaptees a chaque etape de la trajectoire des patients atteints de la...

Is cannabis a useful adjunct in the treatment of symptoms of persons with multiple sclerosis? A formal trial of CBD and THC for the control of spasticity and other symptoms: assessing the clinical effects and the basic mechanisms.

2019/20-2020/21 • $187,500 • PI,CO,Other
Multiple sclerosis (MS) is a chronic disease that manifests as relapses and/or progression. Multiple disease-modifying treatments (DMTs) are available to control the disease process. Lesser progress has been achieved to treat the multiple symptoms that MS can cause. Persons with MS PwMS,...

Chronic non-cancer pain, substance use, and related harms: Towards an optimal treatment pathway for people who inject drugs in the context of the opioid crisis

2020/21 • $100,000 • PI,CO
One in five Canadians lives with chronic pain, an invisible but debilitating, distressing, and costly condition that is complex and difficult to treat. Meanwhile, from January 2016 to June 2019, 13,900 opioid-related deaths were recorded in Canada, with contamination of the illicit drug supply a...

Characterizing mortality rates and associated modifiable determinants among people who inject drugs in a large, urban Canadian city: Implications for future population health interventions

2019/20-2020/21 • $77,301 • PI,CO
People who inject drugs (PWID) often face profound socio-economic disadvantage and are one of the most vulnerable groups in society, with a global mortality rate nearly 15 times that of the general population. Largely concentrated in cities, PWID are disproportionately exposed to housing...

Development of a harm reduction intervention for people with psychosis who use cannabis

2020/21 • $50,000 • Scholarship/Fellowship,Other
The Canadian legalization of cannabis exposed important knowledge gaps that needed prioritizing. While most cannabis users consume without experiencing any negative consequences, certain populations are more vulnerable to cannabis-related harms. For example, people with psychosis who use...

Expanding e-Mental Health Services: The Development and Randomized Clinical Trial of a Technology-based Psychological Intervention for Cannabis Use Disorder in Young Adults with Psychosis

2020/21 • $35,000 • Scholarship/Fellowship,Other
Cannabis ("pot") is the most widely used recreational drug among young adults (18-30 years) in Canada and frequent consumers are at higher risk of developing psychosis. In young adults with psychosis, cannabis use disorder (CUD, a medical term used to describe problematic cannabis use) is common...

The National CIHR Hepatitis C Network (NCHCN)

2015/16-2019/20 • $4,520,000 • PI,CO,Other
Hepatitis C virus (HCV) infection is a global health problem. In Canada, it is estimated that 242,500 individuals are infected with the incidence of approximately 4,000 new cases per year. The majority of newly infected individuals develop persistent infection and chronic liver disease over many...

The complex dynamics of mental health and risk among people who inject drugs: implications for HIV and hepatitis C transmission

2014/15-2019/20 • $1,513,392 • PI,CO
The transmission of HIV and hepatitis C (HCV) contributes substantially to the morbidity and mortality caused by substance use disorders. Injection drug use is one of the main drivers of these two epidemics worldwide. The reasons why persons who inject drugs (PWID) engage in behaviours that put...

Initiation of opioid agonist therapy with daily witnessed methadone or flexible take-home dosing of buprenorphine/naloxone for prescription opioid users: A pragmatic patient-centred randomized controlled trial-QC/Maritimes

2015/16-2018/19 • $1,310,000 • PI,CO
Aucun sommaire

Contribution de l'art au rétablissement et à l'inclusion sociale de personnes marginalisées

2015/16-2018/19 • $213,613 • PI,CO
CONTRIBUTION DE L'ART AU RÉTABLISSEMENT ET À L'INCLUSION SOCIALE DE PERSONNES MARGINALISÉES Nous observons un déplacement des pratiques artistiques et pédagogiques dans des lieux non dédiés à l'art et auprès de populations diversifiées. Ces pratiques, qui ne sont pas de l'art-thérapie,...

Cannabidiol as a new intervention for cocaine dependence

2014/15-2017/18 • $449,788 • PI,CO
This study seeks to determine whether capsules of cannabidiol (CBD) will decrease the desire to use cocaine among dependent individuals during early abstinence, as well as the risk of relapse after detoxification. A growing concern in public health has developed over recent years in regard to...

CRISM-QUÉBEC: Réseau Québécois -Recherche sur les interventions en abus de substances/Research on Interventions for substance misuse

2013/14 • $49,832 • PI,CO,Other
Substance misuse remains a significant global public health problem which carries a heavy burden for abusers and their families alike. This disorder is associated with suffering and severe health problems in patients, distress among family members, as well as tremendous costs to society....

Brevets